212 related articles for article (PubMed ID: 37290232)
1. Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors.
Neshat SY; Chan CHR; Harris J; Zmily OM; Est-Witte S; Karlsson J; Shannon SR; Jain M; Doloff JC; Green JJ; Tzeng SY
Biomaterials; 2023 Sep; 300():122185. PubMed ID: 37290232
[TBL] [Abstract][Full Text] [Related]
2. In situ genetic engineering of tumors for long-lasting and systemic immunotherapy.
Tzeng SY; Patel KK; Wilson DR; Meyer RA; Rhodes KR; Green JJ
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4043-4052. PubMed ID: 32034097
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy.
Kim H; Niu L; Larson P; Kucaba TA; Murphy KA; James BR; Ferguson DM; Griffith TS; Panyam J
Biomaterials; 2018 May; 164():38-53. PubMed ID: 29482062
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.
Buss CG; Bhatia SN
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13428-13436. PubMed ID: 32493746
[TBL] [Abstract][Full Text] [Related]
5. Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing
Luly KM; Green JJ; Sunshine JC; Tzeng SY
ACS Biomater Sci Eng; 2023 Nov; 9(11):6438-6450. PubMed ID: 37797944
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.
Da Silva CG; Camps MGM; Li TMWY; Chan AB; Ossendorp F; Cruz LJ
Biomaterials; 2019 Nov; 220():119417. PubMed ID: 31419588
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol)-Poly(beta-amino ester)-Based Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft Model.
Kim J; Mondal SK; Tzeng SY; Rui Y; Al-Kharboosh R; Kozielski KK; Bhargav AG; Garcia CA; Quiñones-Hinojosa A; Green JJ
ACS Biomater Sci Eng; 2020 May; 6(5):2943-2955. PubMed ID: 33463272
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Local Delivery of Engineered IL-2 mRNA by Porous Silica Nanoparticles to Promote Effective Antitumor Immunity.
Shin H; Kang S; Won C; Min DH
ACS Nano; 2023 Sep; 17(17):17554-17567. PubMed ID: 37643221
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination.
Ben-Akiva E; Karlsson J; Hemmati S; Yu H; Tzeng SY; Pardoll DM; Green JJ
Proc Natl Acad Sci U S A; 2023 Jun; 120(26):e2301606120. PubMed ID: 37339211
[TBL] [Abstract][Full Text] [Related]
10. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
Li S; Bennett ZT; Sumer BD; Gao J
Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
[TBL] [Abstract][Full Text] [Related]
11. Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles.
Da Silva CG; Camps MGM; Li TMWY; Zerrillo L; Löwik CW; Ossendorp F; Cruz LJ
Theranostics; 2019; 9(22):6485-6500. PubMed ID: 31588231
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.
Bielecki PA; Lorkowski ME; Becicka WM; Atukorale PU; Moon TJ; Zhang Y; Wiese M; Covarrubias G; Ravichandran S; Karathanasis E
Nanoscale Horiz; 2021 Feb; 6(2):156-167. PubMed ID: 33400743
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors.
Lorkowski ME; Atukorale PU; Bielecki PA; Tong KH; Covarrubias G; Zhang Y; Loutrianakis G; Moon TJ; Santulli AR; Becicka WM; Karathanasis E
J Control Release; 2021 Feb; 330():1095-1105. PubMed ID: 33188827
[TBL] [Abstract][Full Text] [Related]
14. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
15. Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.
Seclì L; Infante L; Nocchi L; De Lucia M; Cotugno G; Leoni G; Micarelli E; Garzia I; Avalle L; Sdruscia G; Troise F; Allocca S; Romano G; Scarselli E; D'Alise AM
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117006
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Mediated
Walters AA; Santacana-Font G; Li J; Routabi N; Qin Y; Claes N; Bals S; Tzu-Wen Wang J; Al-Jamal KT
ACS Nano; 2021 Oct; 15(11):17549-64. PubMed ID: 34677938
[TBL] [Abstract][Full Text] [Related]
17. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
18. Poly(β-amino ester)-co-poly(caprolactone) Terpolymers as Nonviral Vectors for mRNA Delivery In Vitro and In Vivo.
Capasso Palmiero U; Kaczmarek JC; Fenton OS; Anderson DG
Adv Healthc Mater; 2018 Jul; 7(14):e1800249. PubMed ID: 29761648
[TBL] [Abstract][Full Text] [Related]
19. Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect.
Cheng F; Su T; Zhou S; Liu X; Yang S; Lin S; Guo W; Zhu G
Sci Adv; 2023 Jul; 9(28):eade6257. PubMed ID: 37450588
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
